abstract: Women with mutation in both alleles of the NLRP7 or C6orf221/KHDC3L genes are predisposed to diploid biparental moles, but it has also been suggested that mutation in these genes can predispose to diploid androgenetic or triploid moles and to other kinds of reproductive wastage. We have investigated the association between molar pregnancy and recurrent miscarriages regarding changes in the NLRP7 and C6orf221/KHDC3L genes. Our study group can be divided into three sub-cohorts: (i) women having had at least one molar pregnancy and at least two non-mole miscarriages, (ii) women having had recurrent androgenetic hydatidiform moles and (iii) women having had one diploid androgenetic hydatidiform mole and a relative having had a hydatidiform mole (familial hydatidiform moles). We observed a statistically non-significant tendency of non-synonymous variants in NLRP7 to be more frequent in women with familial hydatidiform mole and in women with female family members with hydatidiform mole or non-mole miscarriage compared with women with no family history of mole or miscarriage. However, we did not find any unequivocal pathogenic mutations (the term 'unequivocal pathogenic mutations' refers to mutations that indubitably have a pathogenic effect on the affected woman) in NLRP7 or C6orf221/KHDC3L in any of the women in the study group. This indicates that recurrent miscarriages plus hydatidiform mole, recurrent androgenetic hydatidiform moles and familial androgenetic hydatidiform moles in general do not have the same monogenetic etiology as familiar diploid biparental moles.
Introduction
Approximately 1% of couples who wish to reproduce will face recurrent miscarriages (RM) before the 22nd gestational week (Jauniaux et al., 2006) . Relatively well-documented risk factors for miscarriage encompass uterine abnormalities, endocrine disorders, presence of lupus anticoagulant or antinuclear antibodies in the woman, and abnormal karyotype in either the woman or her partner (Stephenson, 1996; Baek et al., 2007) . However, in about 50% of couples suffering from RM, none of these factors are found. One specific kind of reproductive wastage is hydatidiform mole (HM). This condition is an abnormal human pregnancy that is characterized by nonexistent, or abnormal, embryonic development, trophoblastic hyperplasia and hydropic enlargement of the chorionic villi.
HMs are divided into two types, complete hydatidiform mole (CHM) and partial hydatidiform mole (PHM) based on histopathological criteria. CHMs do not contain embryonic tissue whereas PHMs may contain some embryonic tissue. Most CHMs are diploid androgenetic (paternal-paternal ¼ PP) and PHMs are mostly triploid diandric (paternalpaternal-maternal ¼ PPM) (Jacobs et al., 1982; Paradinas et al., 1996; Fukunaga, 2001 ). However, rare cases of HM have other genetic constitutions, for instance biparental diploidy (PM) (Vejerslev et al., 1991; Helwani et al., 1999; Fisher et al., 2000; Kou et al., 2008) , and mosaicism combining a diploid androgenetic and a diploid biparental cell line (PP/PM) (Ford et al., 1986; Weaver et al., 2000; Makrydimas et al., 2002; Shiina et al., 2002; Hoffner et al., 2008; Deveault et al., 2009; Sunde et al., 2011) .
HM occurs 1/600 -1000 pregnancies in western countries (Steigrad, 2003; Savage et al., 2010) and the frequency of a second HM among women with one HM is 1-6% (Sand et al., 1984; Berkowitz et al., 1998; Sebire et al., 2003; Horn et al., 2006) . Ten to twenty percent of the women having had an HM pregnancy will also have a non-molar reproductive wastage (Berkowitz et al., 1998; Lan et al., 2001) .
A number of women carrying an autosomal recessive predisposition to diploid biparental molar conceptions due to mutations (the term 'mutation' is used for deleterious changes in the DNA sequence) in NLRP7 have been reported in several independent studies (Sensi et al., 2000; Hodges et al., 2003; Murdoch et al., 2006; Kou et al., 2008; Hayward et al., 2009; Wang et al., 2009; Muhlstein et al., 2011; Dixon et al., 2012) . However, Deveault et al. reported on a large variety of genomic constitutions in molar conceptuses of women carrying mutations in NLRP7 and suggested that mutations in this gene also predispose to early embryo cleavage abnormalities (Deveault et al., 2009) . Mutations in NLRP7 have, besides HMs, been associated with non-molar miscarriage (NMM), stillbirths and intrauterine growth retardation (Murdoch et al., 2006; Qian et al., 2007; Messaed et al., 2011) . Messaed et al. suggested that also rare non-synonymous variants (NSVs, the term 'NSV' is used for a single basepair change in the DNA sequence resulting in an amino acid substitution with unknown effect on the protein) in NLRP7 are associated with RM and/or HM (Murdoch et al., 2006; Qian et al., 2007; Messaed et al., 2011) . On the other hand Dixon et al. did not observe any mutations or rare NSVs in nine women with recurrent androgenetic HMs (Dixon et al., 2012) and Manokhina et al. did not observe an association between NLRP7 NSVs and women with diandric CHM, or triploid conceptions plus additional NMM (Manokhina et al., 2013) .
Recent studies have linked another gene to HM development: KHDC3L mutations were found in four women with familial biparental HM from three different families (Parry et al., 2011) and in three women of African-American, Indian and Turkish origin, respectively, with recurrent HM (RHM) (Reddy et al., 2012) .
We here report the results of a variant screening in the NLRP7 and KHDC3L genes in Danish women with RM plus an HM (RM+HM), in women with RHM, and in women with non-recurrent familial HMs (FHM). Our observations indicate that neither mutations nor NSVs in NLRP7 or in KHDC3L are common causes of RM including an HM, nonfamilial RHM or non-recurrent FHM in a population with low incidence of consanguinity.
Materials and Methods
Since the etiology of NMM and HM might be associated, we chose the following three different groups of women: (i) 19 women with RM with a minimum of two NMMs together with one HM (RM+HM), (ii) five women with RHM and (iii) seven women with a single HM plus one family member on either the woman's or her partner's side having had a HM (FHM).
Samples
The women in this study came from two different sources.
Women with RM1HM from the Danish RM clinics
Among 1000 women with RM referred to the Danish RM clinics at Aalborg Hospital, Aalborg or Rigshospitalet, Copenhagen between 1990 and 2010, 19 women were identified having had one HM in addition to RM (RM+HM). One woman originated from eastern Europe and the remaining women were Danish, all being of Caucasian origin. All had had at least two losses of intrauterine pregnancies before the 22nd gestational week and/ or biochemical pregnancies and one histologically verified HM. Nine of the women also had a family member having had at least one NMM. Details are listed in supplementary data (Supplementary data, Table SI). No established cause of RM had been revealed after routine investigations: The women had normal uterine anatomy, their menstrual cycles were regular with intervals of 21 -35 days, they were negative for lupus anticoagulant and the women and their partners all had normal karyotypes.
Women with RHM and FHM from the Danish Mole Project
In the Danish Mole Project, gynecologists in the western part of Denmark consecutively forward fresh samples of evacuated tissue from clinically suspected HMs and blood samples from the women for genetic analyses. In parallel, representative samples from the evacuated tissue are formalin fixed and forwarded to the local department of pathology. Data about the women and their previous pregnancies were collected from hospital files and pathology reports. A questionnaire asking the women about occurrence of HMs in their own and their partner's families was mailed to all women after the HM diagnosis was confirmed. Between April 1986 and June 2006, 270 conceptuses were included in the Danish Mole Project and diagnosed as HMs. A total of five women had had RHM. One Lebanese woman had had five diploid molar pregnancies with biparental origin and was diagnosed with Familial Recurrent HM. Data on this woman have been published recently (Andreasen et al., 2012) and are not included in the present study. The remaining four RHM women were all of Danish origin and had had two HMs each. The genetic constitution of six of these eight HMs was analyzed and all were diploid androgenetic. We have deliberately omitted cases that came to our notice outside the Danish Mole Project. Details are listed in Supplementary data, Tables SII and SIII) .
Seven women reported having a family member (mother, sister or daughter) in either the patient's (five cases) or the partner's (two cases) family having had an HM. The seven women are referred to as having FHM. All of these families were Danish and Caucasian. Six of these women had HMs with diploid androgenetic genomic origin (PP), whereas one woman had an HM with triploid diandrogenetic origin (PPM). Details are listed in Supplementary data, Table SIII .
The regional Committee on Biomedical Research Ethics approved the study and all women gave written informed consent.
PCR and sequencing
Standard techniques were used to isolate DNA from maternal blood samples.
NLRP7
PCR and Sanger sequencing were performed as described previously (Andreasen et al., 2012) .
KHDC3L
DNA was amplified by PCR using 3 primer pairs as described previously (Andreasen et al., 2012) .
PCR and sequencing were performed as follows: PCR Amplification Kit from Takara Bio, Japan (TaKaRa Taq DNA polymerase, 10× PCR buffer (with 15 mM MgCl 2 ) and dNTP mixture (2.5 mM of each dNTP). Additional PCR reagents were: RNase-free H 2 O, 10 mM of each primer and 50 ng DNA.
PCR conditions using Touchdown PCR were: 5 min at 948C, followed by 15 (exon 1 + 3)/11 (exon 2) cycles of (30 s at 948C, 45 s at 67 -538C (exon 1 + 3)/70-598C (exon 2) (1 degree decrease every cycle), 2 min at 728C), hereafter 20 cycles of (30 s at 948C, 45 s at 538C (exon 1 + 3)/598C (exon 2), 2 min at 728C) and final extension for 5 min at 728C. PCR products were purified using MinElute PCR Purification Kit from Qiagen and sequenced by Sanger sequencing in forward and reverse direction at BGI, Shenzhen, China. The numbering of the NLRP7 and KHDC3L sequences are according to Genbank accession numbers NM_001127255.1 and NM_001017361.2, respectively. Nucleotide numbering is based on the cDNA sequence with A of the translation start codon ATG as nucleotide +1. Amino acid numbering begins with start codon ATG as amino acid +1.
The sequencing results were analyzed with the ChromasPro software (version 1.5, Technelysium Pty Ltd)
Results
We analyzed blood samples from a total of 30 Danish women: 19 women with RM+HM, four women with RHM and seven women with FHM.
NLRP7
The screening revealed no unequivocal pathogenic mutations in NLRP7. However, a total of eight NSVs were observed (Table I and Supplementary data, Table SIV ). Seven of the NSVs have been reported previously, whereas the NSV c.[2396A.C] (p.Asn799Thr) found in heterozygous state in a woman with FHM has not been reported before. We found that having one or more NLRP7 NSVs was more frequent among women with a female family member with either HM or NMM (9/12, 75%, (95% CI: 46 -92%)) compared with women without a female family member with these adverse pregnancy outcomes (7/18, 39%, (95% CI: 20-61%)). One of the previously reported NSVs c.1441[G.A] (p.Ala481Thr) was observed in heterozygous state in six women, with either RM+HM or FHM. This NSV was more frequent in the FHM cohort compared with the RM+HM or RHM cohorts (Table II) , but this tendency did not reach statistical significance. Four of the six women having the c.1441G.A NSV had a sister with either HM or NMM.
KHDC3L
We did not observe any unambiguous pathogenic mutations in KHDC3L. However, we found three NSVs in the coding DNA sequence (CDS) of KHDC3L, c.14G.A, c.289G.C and c.602C.G (Table III) .
Discussion
This study reports the result of NLRP7 and KHDC3L sequencing of 30 Danish women with reproductive problems involving HMs. Nineteen women with RM+HM were collected from a consecutive cohort of women with RM. Four women with RHM and seven women with FHM were collected from a cohort of women that participated in the Danish Mole Project in the western part of Denmark. As consanguinity is rare in Denmark, our data bring information about the frequency and distribution of gene variants in populations without consanguinity.
Caution should be taken, given that we have analyzed small groups. Also, it cannot be excluded that some HMs in the women of the various groups, RM+HM, RHM and FHM, arose by chance since HMs are fairly common, implying that different adverse pregnancy outcomes Exon 1 C.14 G>A Arg5Lys
Exon 2 C.289 G>C Glu97Gln
Exon 3 c.602 C>G Ala201Gly PHM, partial hydatidiform mole; CHM, complete hydatidiform mole; 1 HM, 1 HM not defined as either PHM or CHM; P 1 P 1 , diploid androgenetic homozygous hydatidiform mole; P 1 P 2 , diploid androgenetic heterozygous hydatidiform mole; P 1 P 2 M, triploid androgenetic heterozygous hydatidiform mole. risk of bias of ascertainment; and Danish citizens are registered with unique personal identification numbers, which ensures that all patients can be unambiguously identified.
NLRP7
Mutations in both alleles of NLRP7 cause recurrent biparental HM (Sensi et al., 2000; Hodges et al., 2003; Murdoch et al., 2006; Kou et al., 2008; Hayward et al., 2009; Wang et al., 2009; Muhlstein et al., 2011 (Murdoch et al., 2006; Qian et al., 2007; Messaed et al., 2011) . Also heterozygosity for NLRP7 NSVs has been observed in women with classic HM, diploid biparental HM and in women with NMM, indicating that some NLRP7 NSVs may be associated with these reproductive outcomes even in heterozygous states (Deveault et al., 2009; Messaed et al., 2011; Qian et al., 2011) . In contrast Manokhina et al. did not find association between NLRP7 NSVs and women with a pregnancy history of diploid androgenetic CHM, or triploid conceptions plus additional miscarriages (Manokhina et al., 2013) . Likewise, Dixon et al. did not observe any mutations or rare NSVs in nine women with androgenetic RHMs (Dixon et al., 2012) . We investigated women with RM+HM, diploid androgenetic RHM (PP) or diploid androgenetic (PP) or triploid (PPM) FHM. Our screening did not reveal any unequivocal pathogenic mutations in NLRP7. Instead the screening showed eight NLRP7 NSVs.
We observed non-significantly higher frequencies of half of the individual NSVs among women with FHM compared with women with RM+HM or RHM (Table II) . We did also observe a non-significantly higher frequency of having ≥1 NSV among women with a female family member with a HM or NMM compared with women without a female family member with HM or NMM.
Although these comparisons were made between highly selected groups of women, these observations may be a first indication that (some) NLRP7 NSVs contribute to a familial predisposition of reproductive wastage. In that case, this predisposition likely would not be caused by a monogenic high-penetrance effect. Rather it would be explained by a polygenetic and multifactorial effect. Further studies are needed to elucidate this possible association.
Messaed et al. found association between the NSV c.1441G.A and reproductive wastage including HMs (Messaed et al., 2011) . However in a recent paper, Manokhina et al. did not see this association in women with RM with or without additional triploid HMs, or with CHMs (Manokhina et al., 2013) and Dixon et al. did not observe this NSV in any of nine women with androgenetic RHM (Dixon et al., 2012) .
We observed non-significantly lower frequencies of c.1441G.A in women with RM+HM and in women with recurrent 'classic' HMs (RHM) versus the frequency given by dbSNP 135. This corroborates that the presence of the c.1441G.A NSV does not increase the risk of reproductive wastages including HMs (Table II) .
In addition to the categories studied by others, we analyzed seven women with diploid androgenetic HMs and a family history with HM (FHM). Even though the difference did not reach statistical significance, women with FHM had a higher frequency of the NSV c.1441G.A than women with RM+HM or RHM (Table II) . Furthermore, four of the six women (67%) having the c.1441G.A NSV had a sister with reproductive problems either diagnosed as HM or NMM. These observations may point to an association between a family history of NMMs and/ or HMs and the presence of the c.1441G.A NSV. Thus, based on our small cohort, it cannot be excluded that heterozygoty for certain NSVs in NLRP7 can be a part of a multifactorial etiology of FHMs and familial NMMs. This observation should be challenged in a larger cohort of women with FHM or familial NMMs.
KHDC3L
Mutations in KHDC3L have previously been found in women with familial diploid biparental HMs from four families (Parry et al., 2011; Reddy et al., 2012; Fallahian et al., 2013) and in two unrelated women with diploid biparental HMs but without FHMs (Reddy et al., 2012) .
We found three NSVs in KHDC3L: c.14G.A, c.289G.C and c.602C.G. The NSV c.14G.A, pArg5Lys has been reported before but with a low frequency in the general population (allele frequency: 0.09%, dbSNP 135, UCSC). The NSV changes an arginine in the KHDC3L protein to a lysine. These two amino acids are chemically very similar, both being positively charged amino acids. PolyPhen 2 scores this NSV as being benign. We observed this NSV in heterozygous state in one woman with RM+HM and she did not have any mutation or NSV in the CDS of NLRP7. Although it cannot be excluded that this NSV can have an effect on the KHDC3L protein and thus may be involved in the etiology of reproductive wastage, it is unlikely that it has a major role in the pathogenesis of HM and/or RM. The other two NSVs discovered in KHDC3L (c.289G.C and c.602C.G) are both frequent in the background population (allele frequencies: 33.3 and 47.5%, respectively, in dbSNP 135, UCSC) and were scored as benign in PolyPhen 2. Thus, these NSVs are unlikely causes of HM or RM development.
We cannot exclude that KHDC3L was inactivated, due to alterations in regulatory sequences or due to epigenetic changes, in some of the women. It seems, however, that NSVs in KHDC3L play a minor role, if any, in the development of RM+HM, androgenetic RHM or androgenetic FHM. Mutations in KHDC3L have previously been observed in women with familial biparental HM (Parry et al., 2011; Reddy et al., 2012; Fallahian et al., 2013) . We did not discover any KHDC3L mutations in women with isolated diploid biparental HMs (Andreasen et al., 2012) or in women with FHM or RM including a HM (present study). Likewise, Manokhina et al. did not find any evidence that mutations or NSVs in KHDC3L are associated with either RM+HM or androgenetic HMs (Manokhina et al., 2013) .
Thus, the etiological influence of KHDC3L mutations might be restricted to familial diploid biparental HMs.
Conclusion
No unequivocal deleterious mutations were demonstrated in NLRP7 or KHDC3L in women with RM+HM, androgenetic RHM or diploid androgenetic FHM. This indicates that these pregnancy outcomes in general do not have the same monogenetic etiology as familiar diploid biparental HMs. 
Supplementary data
Supplementary data is available at http://molehr.oxfordjournals.org/.
